Toujeo Pen
Toujeo Pen contains high-concentration insulin glargine (300 units/ml) to provide smooth, continuous blood sugar control for adults and children with diabetes.
Overview
Toujeo Pen is a long-acting insulin formulation containing high-concentration insulin glargine (300 units/ml). It is prescribed to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and type 2 diabetes mellitus. Available through PakMeds with temperature-controlled handling across Pakistan.
Important Information
Prescription medicine: Toujeo Pen is supplied only against a valid prescription from a registered doctor. Use it only as directed by your doctor.
Cold-chain product: Toujeo Pen must be kept refrigerated between 2°C and 8°C. PakMeds delivers it in temperature-controlled packaging. Refrigerate it as soon as it arrives and do not freeze it.
Key Benefits of Toujeo Pen
Provides long-acting and steady blood glucose control.
Helps manage basal insulin requirements in type 1 and type 2 diabetes.
Delivers insulin glargine in a convenient pre-filled SoloStar disposable pen.
Offers a smoother release profile compared to standard concentration insulins.
Toujeo Pen Ingredients and Usage
Toujeo Pen contains insulin glargine, which belongs to the class of long-acting human insulin analogues. It works by replacing the insulin naturally produced by the body and providing a slow, constant supply of insulin over an extended duration.
This medication is indicated for the treatment of diabetes mellitus in adults and children who require long-acting insulin for the control of hyperglycemia. It helps keep blood sugar levels stable throughout the day and night.
How Does Toujeo Pen Work?
Insulin glargine works by lowering blood glucose levels. It stimulates peripheral glucose uptake, particularly by skeletal muscle and fat tissue, and inhibits hepatic glucose production.
The 300 units/ml concentration of Toujeo forms a compact subcutaneous depot after injection, resulting in a prolonged, smooth, and predictable release of insulin into the bloodstream without sharp peaks.
How to Use Toujeo Pen
Toujeo is administered as a subcutaneous injection into the thigh, upper arm, or abdomen. Rotate injection sites with each dose to reduce the risk of lipodystrophy and localized cutaneous amyloidosis.
This injection is given once daily. Your physician determines the exact timing and dose based on your specific blood glucose monitoring results and medical profile.
Never inject Toujeo into a vein or muscle. Always use a new needle for each injection and follow proper injection techniques as demonstrated by your healthcare provider.
Toujeo Pen Side Effects
Toujeo Pen is generally well-tolerated, but like all insulins, it can cause side effects. Contact your doctor if any new or worsening symptoms occur.
Hypoglycemia (low blood sugar)
Injection site reactions such as redness or swelling
Lipodystrophy (skin thickening or pitting at injection site)
Mild peripheral edema (fluid retention)
Weight gain
Allergic skin rash or itching
Warnings
Hypoglycemia is the most common adverse reaction of insulin therapy and can be life-threatening if unmanaged.
Never share a Toujeo pre-filled pen between patients, even if the needle is changed, to avoid cross-contamination.
Re-evaluate dosing under medical supervision if switching between different insulin brands or concentrations.
Severe allergic reactions, including anaphylaxis, require immediate emergency medical attention.
Precautions and Who Should Avoid It
Inform your doctor if you have liver or kidney impairment, as insulin requirements may need adjustment.
Discuss your dose with your physician if you are pregnant, planning to become pregnant, or breastfeeding.
Notify your healthcare provider during periods of illness, infection, emotional stress, or changes in physical activity.
Check your insulin pen carefully before each use to ensure you have the correct formulation and clear solution.
Drug and Food Interactions
Oral antidiabetic medications, ACE inhibitors, and beta-blockers may increase the blood-sugar-lowering effect of insulin.
Corticosteroids, diuretics, and sympathomimetic agents may decrease the blood-sugar-lowering effect of insulin.
Alcohol consumption may increase or decrease the blood-sugar-lowering action of insulin unpredictably.
Thiazolidinediones (TZDs) used in combination with insulin may increase the risk of heart failure and fluid retention.
Toujeo Pen Storage Conditions
Toujeo Pen must be kept refrigerated between 2°C and 8°C in its original pack and must not be frozen. Protect it from direct light and heat. Keep out of the reach of children.
Frequently Asked Questions
What is the difference between Toujeo and standard Lantus?
Toujeo contains insulin glargine at a higher concentration of 300 units/ml compared to Lantus, which is 100 units/ml. This results in a smaller injection volume and a smoother, more extended release profile.
How is Toujeo Pen stored after opening?
Once in use, the pen can be kept at room temperature below 30°C away from direct heat and light for a limited duration specified on the package leaflet. Do not refrigerate the pen while it is in active use.
Can I switch to Toujeo Pen from another insulin on my own?
No, any switch between insulin types or concentrations must be guided and monitored strictly by a qualified doctor to prevent hypoglycemia or loss of glycemic control.
How does PakMeds deliver Toujeo Pen safely in Pakistan?
PakMeds uses temperature-monitored cold-chain packaging to ensure that heat-sensitive items like insulin remain refrigerated throughout transit across Pakistan.
Customer Reviews
No reviews yet. Be the first to review this product!
Login to write a review
